|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 295/08 | |
| C07D 207/26 | |||
| C07C 229/12 | |||
| A61K 31/40 | |||
| A61K 31/195 |
| (11) | Patento numeris | 1268453 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 01912069.0 |
| Europos patento paraiškos padavimo data | 2001-03-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2003-01-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2006-07-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2001/000427 |
| Data | 2001-03-19 |
| (87) | Numeris | WO 2001/077093 |
| Data | 2001-10-18 |
| (30) | Numeris | Data | Šalis |
| 267198 P | 2000-04-07 | US |
| (72) |
DAY, W. W. Pfizer Global Res. & Development, US
JOHNSON, K. A. Pfizer Global Res. & Development, US
PRAKASH, C. A. Pfizer Global Res. & Development, US
EGGLER, J. F. Pfizer Global Res. & Development, US
|
| (73) |
Pfizer Products Inc.,
Eastern Point Road, Groton, CT 06340,
US
|
| (54) | ESTROGEN AGONIST/ANTAGONIST METABOLITES |
| ESTROGEN AGONIST/ANTAGONIST METABOLITES |